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Methods
Rapid identification of homologous recombinants
and determination of gene copy number with
reference/query pyrosequencing (RQPS)
Zhenyi Liu,1 Anna C. Obenauf,3 Michael R. Speicher,3 and Raphael Kopan1,2,4
1Department of Developmental Biology, Washington University School of Medicine, St. Louis, Missouri 63110, USA; 2Division of
Dermatology, Washington University School of Medicine, St. Louis, Missouri 63110, USA; 3Institute of Human Genetics, Medical
University of Graz, Harrachgasse 21/8, A-8010 Graz, Austria
Manipulating the mouse genome is a widespread technology with important applications in many biological fields ranging
from cancer research to developmental biology. Likewise, correlations between copy number variations (CNVs) and
human diseases are emerging. We have developed the reference-query pyrosequencing (RQPS) method, which is based on
quantitative pyrosequencing and uniquely designed probes containing single nucleotide variations (SNVs), to offer
a simple and affordable genotyping solution capable of identifying homologous recombinants independent of the ho-
mology arm size, determining the micro-amplification status of endogenous human loci, and quantifying virus/transgene
copy number in experimental or commercial species. In addition, we also present a simple pyrosequencing-based protocol
that could be used for the enrichment of homologous recombinant embryonic stem (ES) cells.
[Supplemental material is available online at http://www.genome.org.]
Chromosome engineering by random integration (to create
transgenic animals) or by homologous recombination (to replace/
remove specific genes) has been widely used to decipher gene
functions and demonstrate disease causality. However, these
techniques have limitations. The concatenation of transgenes in-
tegrating into the genome makes it difficult to determine copy
number and distinguish homozygotes from heterozygotes. Addi-
tionally, gene-targeting events are infrequent, and identification of
correctly targeted embryonic stem (ES) cells can be laborious. The
advent of the bacterial artificial chromosome (BAC) recombineer-
ing method makes the use of extremely long homology arms (>10
kb) possible, increases homologous recombination efficiency, and
reduces the need of isogenicity between targeting constructs and
recipient ES cells (Muyrers et al. 1999; Cotta-de-Almeida et al.
2003; Testa et al. 2003; Valenzuela et al. 2003; Yang and Seed 2003;
Warming et al. 2005). However, traditional screening methods,
including PCR and Southern blot, are not compatible with ho-
mology arms >10 kb. Alternative screening methods aiming to
solve this problem attempt to either quantify a twofold difference
in the copy number of a targeted allele via quantitative PCR
(Valenzuela et al. 2003) and multiplex ligation-dependent probe
amplification (MLPA) (Langerak et al. 2005) or to visualize in-
tegration sites by fluorescence in situ hybridization (FISH) (Yang
and Seed 2003). These technologies remain technically de-
manding (Gomez-Rodriguez et al. 2008). (Refer to Supplemental
Table S1 for the comparison of current screening methods.)
In addition to investigator-initiated genome manipulation,
recent studies reveal that the human genome contains copy
number variations (CNVs), and such gains or losses of genomic
DNA contribute to disease susceptibility (Gonzalez et al. 2005;
Aitman et al. 2006; Fanciulli et al. 2007; Hollox et al. 2008). Various
methods have been developed to investigate CNVs at either ge-
nome-wide or locus-specific levels (Aten et al. 2008; Lee and Jeon
2008). By labeling test and reference DNAs with different fluores-
cence dyes and hybridizing them to millions of printed probes on
a single array, the comparative genome hybridization (CGH)
method is suitable for whole-genome CNV scanning and has since
revolutionized our understanding of CNV frequency in mamma-
lian genomes (Kallioniemi et al. 1992; Pinkel et al. 1998; Carter
2007). Recently, array-based technologies once specialized for SNP
(single nucleotide polymorphism) genotyping have beenmodified
for genome-wide CNV studies (Carter 2007; Lee and Jeon 2008). In
addition, the advent of the next-generation sequencing methods,
including 454 Life Sciences (Roche)/FLX, Illumina/Genome Ana-
lyzer, and Applied Biosystems SOLiD, offers even more powerful
means to detect CNVs at the whole-genome level (Mardis 2008).
However, all of thesemethods are still relatively expensive and are,
therefore, not optimal for the diagnostic analysis of a large number
of samples (Aten et al. 2008). Moreover, CNV data obtained from
genome-wide studies often require further validation at the single
locus level.
Current methods for studying CNV at the locus-specific level
include real-time PCR (Fanciulli et al. 2007), multiplex quantita-
tive PCR (Charbonnier et al. 2000), MLPA (Schouten et al. 2002),
and the paralog ratio test (PRT) (Armour et al. 2007). Among these,
both real-time and multiplex PCR are customizable but require
careful optimization of reaction conditions. MLPA is gaining
popularity owing to its multiplex capability, but commercially
available probes are currently limited to a small number of human
genes, and the difficulty of probe preparation makes custom-
ization arduous. The PRT method could accurately measure gene
copy number and has been successfully used for the association
study between CNVs of the beta-defensin gene and psoriasis
(Hollox et al. 2008), yet it depends on the presence of an endog-
enous pseudogene as a reference (Armour et al. 2007), which limits
its utility. Clearly, a simple method that could accurately measure
any desired CNVs, identify homologous recombinants in any
species, and correctly enumerate the copy number of any in-
tegrated DNA fragment of any length will be of value to the aca-
demic, commercial, and clinical fields.
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Here we describe a novel approach based on converting these
quantitative problems into a determination of single nucleotide
variation (SNV) frequencies by pyrosequencing. Pyrosequencing
sequences single-strand DNA by coupling nucleotide incorpora-
tion onto a sequencing primer with the production of biolumi-
nescence signals, producing readouts called ‘‘pyrograms’’ (Ronaghi
et al. 1998) (http://www.pyrosequencing.com/). Each peak in
a pyrogram corresponds to a specific nucleotide, and the height is
proportional to the amount of nucleotide incorporated during
each synthesis step (see Fig. 2; Ronaghi et al. 1998). Pyrose-
quencing has gained enormous popularity in DNA methylation
analysis (Uhlmann et al. 2002; Tost and Gut 2007), microbial
identification (Clarke 2005), detection of allelic expression im-
balance (Wang and Elbein 2007), and next-generation sequencing
(454 Life Sciences (Roche)/FLX; http://www.454.com/). In partic-
ular, pyrosequencing has been widely used for SNP detection
(Fakhrai-Rad et al. 2002; Langaee and Ronaghi 2005; Ronaghi et al.
2007) because it offers an easy, quantitative, and accurate method
to detect the relative abundance of alleles in a mixture, provided
they differ by a single nucleotide and that their relative fraction is
between 10% and 90% (Ronaghi et al. 1998; Wasson et al. 2002).
We realized that with two simple modifications, pyrosequencing
could be used to effectively identify changes in copy number at
any locus: First, insertion of SNVs into the probes (a reference
probe and a query probe) eliminates the reliance on natural vari-
ation among alleles. Second, if the reference and query probes are
ligated into a single reference/query pyrosequencing (RQPS)
probe, their molar ratio will be fixed at 1:1, allowing elucidation of
the copy number by pyrosequencing these two SNVs in mixtures
of the test DNA and the RQPS probe. We show here that RQPS
could easily determine the copy number of any query gene (or
DNA fragment) in a genome, be it a man-made transgene, the re-
sult of a natural CNV (including both gain and loss), or gene loss as
a result of homologous recombination. Unlike previous methods
(Pielberg et al. 2003; So¨derba¨ck et al. 2005), RQPS does not require
any prior knowledge of the duplication break point or an endog-
enous reference fragment. It thus offers a flexible and universal
CNV determination tool that can be applied to any individual
fromany species. In addition, it is ideal for the detection of targeted
genes in ES cells. The simplicity, automation-friendly protocols,
and low cost make it suitable for processing a large number of
samples for any specific locus, which could be particularly useful
for clinical disease-related CNV screening and patient diagnosis.
In the course of developing RQPS, we established new pro-
tocols that enable fast and economic enrichment for homologous
recombinant ES cells by simple modifications of the targeting
vectors. This is achieved by introducing one SNV into a mouse
phosphoglycerate kinase 1 (Pgk1) promoter, which drives the ex-
pression of the antibiotic selective cassette, and another into one
of the homology arms of the targeted gene. Only male ES cells
experiencing homologous recombination would display an equal
ratio between the introduced SNVs residing in the targeting con-
struct and the respective endogenous loci for both Pgk1 and the
targeted allele (for details, see Fig. 5). A simple pyrosequencing
screen (pyroscreening) could reduce the screening task by re-
moving up to 80% of nonhomologous ES cell clones from the
candidate pool. This significantly reduces the effort and increases
the number of clones that can be screened effectively for hard-to-
target regions. While we demonstrate the utility of RQPS for
identification of homologous recombinants in ES cells and show
that RQPS, either alone or in combination with pyroscreening,
provides an easy, safe, cheap, BAC and conventional targeting
vector compatible ES cell screeningmethod, its real strength is that




Unambiguous identification of positive homologous recombi-
nants (HR), independent of homology arm length, is desired to
facilitate the use of BAC targeting vectors. To achieve this, we de-
veloped the RQPS method (Fig. 1). The key to this method is the
creation of a DNA probe consisting of two fused DNA fragments.
The first fragment is designed from a reference gene with known
copy number, preferentially one that produces a haploinsufficient
phenotype (to ensure both copies are present), and the second
from the query gene. Importantly, each of the fragments could be
as short as 50 bp and designed to contain a novel SNV to differ-
entiate the probe from the wild-type allele. Such probes can be
created by cloning andmutagenesis, by synthesis of long oligos, or
by PCR amplification with primers containing desired SNVs. This
Figure 1. Schematic illustration of RQPS. A RQPS probe, which consists
of a DNA fragment from the query gene physically linked to a DNA
fragment from a reference gene, both containing artificially designed
SNVs, is mixed with genomic DNA samples to attain a molar ratio
between 1:9 and 9:1. The molar ratio of R-SNV, Q-SNV between probe
and sample genomic DNA in each mixture is accurately determined
by quantitative pyrosequencing. If the query gene is diploid, %G/%A =
T%/C% (wild type, WT in the diagram). If one copy of the query gene is
lost, %G/%A < T%/C% (loss of homozygosity, LOH in the diagram). If
multiple copies of the query gene are present, then %G/%A > T%/C%.
See text for details.
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strategy ensures that the two artificial SNVs in the mixture are al-
ways at a 1:1 molar ratio.
Figure 1 describes how to determine the copy number of any
query gene (endogenous, integrated, or episomal). First, the RQPS
probe is added to genomic DNA samples of known concentration.
Since pyrosequencing is most accurate in mixtures where the
percentage of SNVs is between 10% and 90% (Wasson et al. 2002),
two mixtures are generated for each sample. In the first, the molar
ratio of the RQPS probe to sample genomicDNA is;1:1, and in the
second it is higher (accuracy is not important; more probes may be
added when the query copy number is very high). We define the
reference SNV as R-SNV and the query SNV as Q-SNV. In this ex-
ample, assume that the probe R-SNV is a guanine (G), the probe
Q-SNV is thymidine (T), the sample reference (R) (genomic or
other) is adenine (A), and the sample query (Q ) is cytidine (C);
then the total (100%) of (R-SNV) + (R) in the mixture (%G +%A) is
equal to the total (Q-SNV) + (Q ) or (%T +%C).When an autosomal
gene with two copies per genome is used as a reference, m is de-
fined as the fraction of R-SNV and n is defined as the fraction
of Q-SNV in amixture, the fraction of R (%A) is (1%G) or (1m)
and the fraction of Q (%C) is (1  %T) or (1  n). While the sum
(R-SNV) + (R) is always equal to (Q-SNV) + (Q), the T/C ratio is equal
to the G/A ratio only if the query, like the reference gene, is
a diploid locus. T/C would be twice G/A if one query allele is lost
(as expected if a homologous recombination has occurred and one
copy of thewild-type allele is deleted or replacedwith the payload).
If many copies of a query transgene (or virus) were integrated, T/C
would have a smaller value than G/A. In a more abstract form, the
molar ratio of probe to sample in themixture (G/A above) could be
expressed as 2m/(1m) for a diploid locus. This ratio is equal to tn/
(1  n), where t is the copy number of the query gene in the ge-
nome. (If the query is also a diploid locus, t = 2; ifmore copies of the
query are present, then t > 2. SeeMethods for details.) To derive the
value (t), we plotted the G/A values against the T/C values to pro-
duce a line with zero intercept and calculate its slope (k). The value
(t) is equal to 2k (t = 2k) when the diploid reference locus is used. To
increase the accuracy, we plotted at least two m/(1  m) values
obtained in different reaction mixtures against n/(1  n) values of
the corresponding mixture. A graphic representation of these cal-
culations is shown in Figure 1.
Gene copy number determination with RQPS
To demonstrate the utility of this method, we determined the
gender of 18 animals in a blind experiment by applying RQPS to
assess the copy number of the X-linked Pgk1 gene (males have one
X chromosome, females have two).Wemade a plasmid containing
a ligated fragment from the Pgk1promoter (as the query probe) and
a fragment from a Notch2 exon (as the reference probe) (Fig. 2A).
Each was mutated to include a SNV. Two mixtures with different
ratios of Notch2-Pgk1 RQPS probe to genomic DNA were prepared
and quantitatively pyrosequenced in four reactions per individual,
one for each SNV in each mixture (Fig. 2B). The m/(1  m) value
was plotted against n/(1 n) usingMicrosoft Excel (see example in
Fig. 2C). The animals were segregated into two groups: one with
the slope k = 0.6 and another with the slope k = 1.2, consistent with
t = 2k values of 1.2 for males and 2.4 for females (Fig. 2D,E). Im-
portantly, the gender of all of the animals was correctly de-
termined.
To further assess the accuracy of RQPS, we next measured the
copy number of exon 30 in the Notch1 intracellular domain
(N1ICD) in four different transgenic lineswith clearly defined copy
numbers (see Methods) (Murtaugh et al. 2003; Vooijs et al. 2007).
The RQPS probe used for this experiment consisted of two short
DNA fragments, one from Notch1 exon 23 and another from exon
30, mapping to Notch1 extracellular and intracellular domains,
respectively, and fused together to function as reference and query
probes (Methods; Supplemental Table S2). The slopes (k) obtained
were;0.6, 1.1, 1.6, and 2.1 (Fig. 2F), correctly identifying animals
with t = 1, 2, 3, and 4 copies of exon 30. This analysis was suc-
cessfully repeated with additional Notch1 alleles under character-
ization in our laboratory, correctly identifying the number of
N1ICD in various genomes.
Importantly, in mice containing the N1 + /D1 allele, which
harbors a deletion removing exons 23–30 (Conlon et al. 1995),
only one copy of exon 23 is present in the genome. When ana-
lyzingN1 + /D1; Gt(ROSA)26SorNotch/NotchDNA, we obtained a slope
of k = 3.1 because three copies of exon 30 were present as expected
and the reference allele is haploid (where t = k) (Fig. 2F,e). This
highlights the importance of selecting a reference gene with
a known copy number; selection of a haploinsufficient locus as
a reference will ensure that the reference DNA is present in two
copies per genome in healthy individuals.
Transgene copy number and zygosity determination with
RQPS
The frequent use of transgenic Cre lines and the difficulty in de-
termining transgene copy number motivated us to apply RQPS to
differentiate homozygous from heterozygous pups, a task that
previously required knowledge of the transgene integration site or
a test breeding. For this purpose, a general RQPS probe (Notch2-Cre
RQPS) was prepared. Pax3-Cre transgenic mice (Li et al. 2000) were
chosen for proof-of-principle analysis since the copy number and
integration site of this transgene remained unknown. As shown in
Figure 3A, we calculated the value (t) for fourmale pups by plotting
the results from different probe dilutions for each genomic DNA
sample.We observed three lineswith the slope k =;8 and onewith
the slope k =;16.Multiple rounds ofmating these studswithwild-
type females confirmed that RQPS identified the lone homozygous
male (Fig. 3A). Simultaneously, RQPS estimated the Pax3-Cre
transgene copy number in hemizygotes to be roughly 16 (Fig. 3A).
To determine if the Notch2-Cre RQPS probe could be used as
a universal reagent for all Cre transgenic mice, we tested the Tet-O-
Cre (Perl et al. 2002) and Six2-Gfp::Cre (Humphreys et al. 2008)
lines and determined that both contained two copies in hemi-
zygotes (Fig. 3B; Supplemental Fig. S1). These results validated
RQPS as a rapid, simple solution for the simultaneous de-
termination of transgenic breeder zygosity and copy number. (The
Notch2-Cre RQPS probe is available upon request.)
Detection of copy number variation in human patients
using RQPS
We next tested if RQPS could be used to measure the gene copy
number in seven human patient samples previously found to have
duplication or loss of specific loci with array-CGH. Without know-
ing if loss of homozygosity (LOH) or duplication had occurred, the
samples were subjected, in a semi-blind manner, to RQPS using
probes consisting of small DNA fragments from genes located in
the aberrant region, as query, and NOTCH2, as reference. The re-
sults obtained from five samples by RQPS were consistent with
array-CGH data, including all four LOH cases and one duplication
(Table 1). However, RQPS results conflictedwith array-CGH for two
Rapid determination of gene copy number
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samples. In both cases, the readout from
RQPS was smaller (two copies by RQPS
vs. three copies by array-CGH). Since the
RQPS probes that we designed did not
overlap with array-CGH probes, this
could reflect a scenario wherein the re-
gion covered by the 60-bp-long array
probe is duplicated, whereas the region
detected by our RQPS probe is not. In-
deed, when RQPS probes were redesigned
to match the array-CGH probes, the two
methods produced consistent results,
identifying duplication in both loci. The
discrepancy between the exact copy
numbers (three copies vs. four copies)
may not be surprising since probe re-
sponse to ratio change in oligonucleotide
arrays tends to be suppressed (Carter
2007). These data demonstrate that RQPS
offers an economic alternative for con-
firmation of array-CGH results and is
particularly effective in detecting defined
deletions/amplifications. RQPS could be
also used to map the boundaries of CNV.
Screening for homologous
recombinants in ES cells
Next, we used RQPS to determine if we
could correctly identify homologous re-
combination in ES cells by detecting the
loss of one allele at the targeted locus. We
tried this with ES cells that were elec-
troporated with the N1::CreERT2 con-
struct. Homologous recombination will
replace the Notch1 intracellular domain
with DNA encoding CreERT2 and a FRT
flanked selective marker; hence, only one
wild-type allele remains in HR clones. We
tested 32 ES cell clones enriched for HR
candidates using a RQPS probe contain-
ing the Notch2 reference fragment and
a query DNA fragment corresponding
to the intracellular domain of Notch1
(Notch2–Notch1 RQPS) (see enrichment
protocol below; Supplemental Table S3).
Most clones had k-values of ;1 (diploid),
but nine clones had k-values near 0.5, as
expected if one Notch1 allele is lost (Fig.
4A). A Southern blot of all 32 clones con-
firmed the identity of the nine clones (Fig.
4B), and RQPS correctly identified all the
homologous recombinants in this pool.
Therefore, the RQPS screening produced
an accurate, simple, BAC-compatible HR
identification protocol.
Enrichment for HR by incorporating
SNV(s) into targeting vectors
RQPS can work as a primary screening
method to accurately identifyhomologous
Figure 2. RQPS accurately determines gene copy number. (A) Illustration of the Notch2-Pgk1 probe
with SNVs introduced to differentiate it from the genomic counterparts. In the RQPS probe, the reference
Notch2 fragment has a G-to-C SNV while Pgk1 has a C-to-G SNV. The fragment containing the Notch2
SNV was amplified with a three-primer system: (1) the forward tailed primer F1 with a complementary
region to (2) the universal biotinylated primer (UBP), and (3) the untailed reverse primer R1. The frag-
ment containing the Pgk1 SNV was amplified with the same UBP primer and two gene-specific primers
(untailed forward primer F2 and a tailed reverse primer R2). The biotinylated PCR product was purified
with streptavidin-coated Sepharose beads and sequenced with a sequence primer (S1 forNotch2 and S2
for Pgk1, respectively) hybridizing near the desired SNV. (B) Example of a readout (pyrogram) from
a Biotage PSQ96-MA machine. Two probe/genomic DNA mixtures were prepared in this example.
Reference and query SNVs were quantified by pyrosequencing of each mixture; the relative ratio is
shown. Note that a G, instead of a C, determines the ratio of the RQPS probe in eachmixture because the
sequencing primer for the Notch2 reference gene binds to the minus strand. (C ) The plot of m/(1  m)
against n/(1 n) gives a line that passes (0, 0) with slope k = 0.59, which suggests that there is one copy
of Pgk1 in this mouse and hence it is a male. (D) RQPS accurately assigns gender by determining the
copy number of the X-linked Pgk1 gene. All male mice show a k-value of;0.6 and all females;1.2. (E )
Statistical analysis of k-values from 18 animals tested demonstrates the robustness of RQPS. (F ) RQPS
accurately measures the copy number of exon 30 from the Notch1 gene, encoding a part of the Notch1
intracellular domain, in five different lines of mice that are known to have (a) one, (b) two, (c,e ) three,
and (d) four copies of the NICD1, respectively. When the N1 + /n1;Gt(ROSA)26SorNotch/Notch mouse is
used, owing to a deletion removing exon 30 (query) and exon 23 (reference) from one allele (Conlon
et al. 1995), three copies of N1 ICD produced k = 3.1 since a haploid reference gene was used (e).
Liu et al .
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recombinants regardless of homology-arm (HA) lengths, but it is
still laborious if one is to screen hundreds of ES cells. To simplify
the task and enrich for ES cells that experienced homologous re-
combination events independent of HA size, we introduced an-
other simple innovation: insertion of two SNVs to the targeting
vector (Fig. 5A). As mentioned in the introduction, one SNV is
placed on the homology arm (the HA-SNV), roughly 50 bp away
from the payload; the other was inserted into the neomycin se-
lection cassette, using the same Pgk1 promoter SNV described in
Figure 2. Enrichment for putative HR is accomplished by simply
examining the ratio of these SNVs to their endogenous counter-
parts in a single quantitative pyrosequencing reaction (Fig. 5A).
Because most facilities use male (XY) ES cells, only ES cell clones
that have experienced a single integration, homologous or ran-
dom, would display an allele ratio of 1:1
for the X-linked Pgk1 SNV. Any additional
integration will increase the proportion
of the vector Pgk1 SNV (two integration
66%, three 75%, etc.). On the other hand,
the HA-SNV will only show a 1:1 ratio in
homologous recombinants or in cells that
experienced two random integrations,
while under all other conditions, the frac-
tion of HA-SNV will fall either around
33% (one random integration) or above
60% (at least three integrations). There-
fore, only HR will display a 1:1 ratio for
both SNVs. We called this enrichment
method ‘‘pyroscreening.’’
As a proof-of-principle, ES cells were
electroporated with one of five differ-
ent gene targeting constructs (a detailed
description of each line will be pro-
vided elsewhere). Four of the five vectors
were constructed in C57/B6 BAC clones
using the BAC recombineering method
(Warming et al. 2005), during which the
desired SNVs were incorporated (Supple-
mental Fig. S2). Although pyroscreening
is insensitive to HA length and should work equally well with BAC
targeting vectors, we subcloned each targeting construct into a
plasmid before electroporation into ES cells to facilitate parallel
analysis with traditional PCR and Southern blot screening
methods. Of these targeting vectors, two contained only the HA-
SNV, while the other three also contained Pgk1 SNVs. Colonies
were picked from cells selected by G418 resistance, expanded on
mouse embryonic fibroblast (MEF) cells, and 808 clones were
pyroscreened. As quantitative pyrosequencing has an error rate of
;5%, we collected all clones with pyrosequencing readout be-
tween 40% and 60% (50%6 23 5%) and tested them for enriched
HR candidates. Even when only a single SNV was used, PCR
analysis confirmed that a threefold enrichment was achieved (Fig.
5C; Supplemental Fig. S3). With two SNVs, a fourfold enrichment










1 Chr. 12:51493655–52217545 MAP3K12; SP1; KRT18; ZNF740 SP1 exon3 2b 3
1a Chr. 12:51493655–52217545 MAP3K12; SP1; KRT18; ZNF740 SP1 CGH probe region 4c 3
2 Chr. 22:46857948-tel TRABD; MAPK12; FAM19A5 TRABD 1 1
3 Chr. 2:88110094–88925173 SMYD1; FABP1; RPIA; EIF2AK3 FABP1 exon1 2b 3
3a Chr. 2:88110094–88925173 SMYD1; FABP1; RPIA; EIF2AK3 FABP1 CGH probe region 4c 3
4 Chr. 9:2924366–4409742 RFX3; GLIS3 RFX3 1 1
5 Chr. 9:tel-24136507/Chr.13:
19558594–36717548
RFX3; GLIS3; JAK2; PSIP1; MTAP;
BRCA2; SMAD9; SACS; TNFRSF19
SMAD9 3 3
6 Chr. 17:7122558–7868524 TP53; TNK1; NLGN2; ATP1B2; FGF11;
SOX15
FGF11 1 1
7 Chr. 18:957962–12021803 RAB12; ARHGAP28; RALBP1; NAPG RALBP1 1 1
For each sample, an RQPS probe, consisting of an exon fragment (;50 bp) from within a randomly selected query gene residing within the CNV region
fused to a NOTCH2 fragment, was prepared. Both fragments were mutated to contain an SNV. These probes were then used to estimate the copy number
of seven loci in a semi-blind test. After RQPS, the results were compared to previously determined array-CGH data. Two discrepancies were found, which
were resolved when RQPS was repeated with query sequences matching the CGH probe.
aRepeat reaction with RQPS probe matching the CGH probe.
bInconsistent result between RQPS probe to a region not covered by a CGH probe and the CGH array.
cBoth RQPS and array-CGH data detected amplification; they differ in estimating copy number.
Figure 3. RQPS differentiates homozygous from heterozygous transgenic animals. (A) RQPS on four
Pax3-Cre animals. In this experiment, four different dilutions of RQPS probe were made with genomic
DNA samples from each mouse; this was done to demonstrate that any two concentrations would have
worked as well. Note the very small standard deviations for each data point, indicating that triplicates or
duplicates are not necessary. Pyrosequencing of each mixture was performed in triplicate, and the
average values were plotted; the standard deviation of each data point is shown. (B) RQPS of Tet-O-Cre
mice. The copy number of the Tet-O-Cre transgene was measured in four animals. Four different mix-
tures were pyrosequenced in duplicate for each sample. RQPS detected two homozygotes and two
heterozygotes, with about two and four copies of the transgene, respectively.
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for HRwas attained by selecting clones with an;50% SNV ratio for
both Pgk1 andHA (Fig. 5B,C). Comparisonwith traditional PCR and
Southern blot screening of the entire population determined that
only two of the 21 positive HRs were missed by pyroscreening (Fig.
5B; Supplemental Figs. S3 and S4). Pyroscreening is thus an effective
enrichment protocol, streamlining the analysis process by elimi-
nating ;80% of all G418-resistant clones prior to RQPS, PCR, or
Southern blot analysis with an estimated false-negative rate of
;9.5% (Supplemental Table S3). The false-positive clones are most
likely due to the contamination ofMEF cells, which affect the ratios
of both HA and Pgk1 SNVs. We expect fewer or no false-positives if
ES cells are grown without MEF cells. The SNV-containing selection
cassette we have created (eukaryotic Pgk1/prokaryotic EM7 dual
promoter-driven neomycin/kanamycin flanked by FRT site) is
available upon request and should facilitate pyroscreening.
Discussion
We report here the adaptation of quantitative pyrosequencing to
measure the copy number for any gene or DNA fragment in any
species and its use in detecting homologous recombinants, trans-
gene copy number, zygosity, andCNV validation. In order to apply
pyrosequencing to any sequence, the investigator needs to gen-
erate a RQPS probe consisting of two SNV-containing fragments
with homology with a query locus and a reference locus, re-
spectively. Query loci could be integrated DNA or endogenous loci
that underwent micro duplication or loss of DNA. The design of
the SNV-containing RQPS probes renders our method in-
dependent of naturally occurring SNPs and reference alleles, dis-
tinguishing it from other pyrosequencing-based CNV detection
methods reported so far (Pielberg et al. 2003; So¨derba¨ck et al.
2005). This endows RQPS with great flexibility while retaining the
simplicity and cost effectiveness of pyrosequencing. Once a probe
is made for a specific locus of interest, a large number of samples
could be easily and economically processed, which makes RQPS
ideal for high-throughput clinical diagnosis of the CNV status at
a limited number of loci.
Another application we demonstrated is an enrichment pro-
tocol to identify potential homologous recombinants. By in-
troducing two artificial SNVs, one into the Pgk1 promoter of the
selection cassette and the second into the homology arm, most
negative clones can be discarded (Fig. 5). It is important to point
out that the MEF feeder cells used in this study are derived from
the F1 embryos of a cross between Jackson transgenic C57BL/
6J-Tg (pPWL512hyg)1Ems/J homozygotes and C57BL/6J-TG
(pPGKneobpa)3Ems/J homozygotes. In such cells, both hygro-
mycin- and neomycin-selective cassettes are driven bymouse Pgk1
promoters. Assuming an equal number of male and female MEF
cells, at least one copy from each transgene and 1.5 copies from the
endogenous Pgk1 gene are present, and thus each MEF cell con-
tains at least 3.5 copies of Pgk1 promoter. Despite this confounding
factor, we achieved an overall threefold enrichment even with
a single SNV pyroscreening. Better performance of pyroscreening
will be attained when ES cells are grown without feeder cells
(Nichols et al. 1990). It is worth noting that placing a homology-
arm, silent SNV into an exon in the gene-targeting construct offers
the important additional benefit of distinguishing the two tran-
scripts generated from the endogenous and targeted alleles by
quantitative pyrosequencing on reverse-transcribed cDNA.
In contrast to pyroscreening, ES cells can be directly screened
with RQPS independent of targeting vectors. Like Q-PCR, RQPS
screens for positive clones by detecting the loss of one wild-type
allele in the targeted locus (Valenzuela et al. 2003). Yet unlike
Q-PCR, RQPS does notmeasure a twofold reduction in the amount,
but rather determines the ratio of two different nucleotides. Be-
cause the relative ratio of alleles in a mixture is measured within
a single tube, system errors are minimized. We have shown that
RQPS can correctly identify all positive clones after enrichment by
pyroscreening and could thus replace the Southern blot screening
method. As BAC recombineering has made the construction of
a large number of gene targeting vectors in a short period of time
possible (Valenzuela et al. 2003), the automation-friendly RQPS,
alone or in conjunction with pyroscreening, will effectively stream-
line the ES cell screening process.
Methods
Generation of targeting constructs
The five targeting constructs described in the text are: (1) Notch1::
creHi; (2) Notch1::CreERT2, in which the Notch1 intracellular do-
main (ICD) is replaced with Cre recombinase or tamoxifen-
inducible CreERT2 fusion protein, respectively; (3) Notch2::cre,
in which the Notch2 ICD is replaced with Cre recombinase; (4) N2-
N1, in which the Notch2 ICD is replaced by the Notch1 ICD; and
(5) N1-N2 in which the Notch1 ICD is replaced by the Notch2 ICD.
To explain how SNVs are simultaneously incorporated into a tar-
geting construct through BAC recombineering, we provide details
of constructing the N1::CreERT2 vector (below; Supplemental
Figure 4. Identifying HR clones in targeted ES cells using RQPS. (A)
Refined screening of 32 ES cells falling within group A (Fig. 5B). Two dif-
ferent dilutions of RQPS probe were made for each ES cell genomic DNA
sample and pyrosequenced. The black bar represents HR candidates
(clone ID shown) with k-values indicating loss of one Notch1 allele. R2
values for a zero intercept line are also plotted. (B) All HR candidates
identified in A were confirmed by Southern blot, each containing the WT
allele fragment (6 kb) and the targeted allele fragment (4.6 kb) expected
after KpnI digestion.
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Fig. S2). The construction details and rationale for designing the
remaining constructs will be described elsewhere.
In brief, a 6Xmyc-tagged CreERT2 fusion gene was first cloned
in front of a FRT-flanked neomycin selection cassette, whose ex-
pression was under the control of bothmouse Pgk1 and Escherichia
coli EM7 promoter. An artificial SNV was introduced into the
mouse Pgk1 for pyroscreening by site-directed mutagenesis. Next,
we amplified a fragment containing the blastidin promoter-driven
ampicillin-resistance gene using pBlueScript as a PCR template.
Two pairs of flankingmini-HAwere added in subsequent rounds of
PCR. The outer mini-HAs (magenta) mediated the recombination
of the fragment into a Notch1 BAC; the inner mini-HAs (cyan) me-
diated subsequent replacement of the ampicillin cassette by recom-
bination of a payload cassette (6xMyc-CreERT2FRT; PGKEM7-Neo).
In addition, a second SNV was inserted into the outer mini-HAs
(Supplemental Fig. S2). This strategy (insertion of the mini-HR)
circumvents the need to amplify the
payload in order to introduce homology
arms into it and thus facilitates the in-
sertion of large DNA fragments into a
BAC. For the studies described here, the
CreERT2FRTNeo cassette with 4.8 kb
upstream and 2.2 kb downstream flank-
ing BAC DNA was recombined into
a pBluescript plasmid as described (Liu
et al. 2003).
ES cell electroporation
Forty micrograms of linearized targeting
construct was electroporated into either
129 derived SSC10 (for N1::creHi) or
C57BL6 derived B6/BLU (all other con-
structs) ES cells by the Siteman Cancer
Center ES Core at Washington University
(http://escore.im.wustl.edu). Neomycin-
resistant clones were selected by the core
and expanded by the investigators for
further screening.
PCR and Southern blot screening of ES
cells
Nested PCR was used for the screening of
ES cells that were electroporated with
targeting vectors with long HAs. Purified
BAC DNA containing a desired targeting
construct was diluted with wild-type
mouse genomic DNA and used as a posi-
tive control for the optimization of PCR
conditions. PCR primers with the ex-
pected size of the PCR products are listed
in Supplemental Table S4. The 25-mL PCR
reaction included: 2.5 mL of 103 PCR
buffer, 0.25 mL of KlenTaqLA (Sigma), 0.5
mL of 10 mM dNTP mixture, 1 mL each
of 20 mM upstream and downstream
primers, 8.25 mL of 4 M betaine, and 1 mL
of DNA template of unknown concen-
tration. The PCR cycle conditions were
5 min at 94°C, followed by 35 cycles of
94°C (1 min), 50°C ;65°C (1 min, based
on primer sequence), 68°C (2–5 min de-
pending on the amplicon size at 1 min/
kb), and finally 10 min at 68°C. The
Southern blot was done as described (Sambrook and Maniatis
1989) with [a-32P32]dCTP labeled probes (GE Healthcare).
Pyrosequencing
For each measurement, we PCR-amplified the SNV-containing re-
gionwith two target-specific primers flanking the desired SNV, one
of which (a tailed primer) included a universal sequence comple-
mentary to a third, the universal biotinylated primer (UBP) (Fig.
2A; Fakhrai-Rad et al. 2002; Royo et al. 2007). All primers were
designed using Pyrosequencing Assay Design Software (Biotage)
(Supplemental Table S2). It is worth noting that the PCR amplifi-
cation efficiency of fragments that differ by only a single SNV in
the same PCR reaction mixture is the same unless the SNV creates
or disrupts a stable secondary structure, a complication that can be
avoided when the SNV is chosen by the investigator. Single-strand
Figure 5. Pyroscreening of artificially introduced SNVs in targeting constructs dramatically enriched
for positive HR clones. (A) Schematic illustration of pyroscreening. Artificially designed SNVs are in-
troduced into targeting constructs: one in the HA (;50 bp away from payload) and another one in the
mouse Pgk1 promoter driving the expression of the selection marker. Different fates of the targeting
construct in ES cells (HR, homologous recombination; RI, random integration) yield different ratios of
the two linked SNVs to their endogenous counterparts. See text for details. (B) Pyroscreening of ES cells
electroporated with (black dots) N1::CreERT2, (green squares) N2::cre, and (blue triangles) N1–N2. ES
cells cluster into different groups. (Group A) Both HA and PGK SNV ratios fall between 40% and 60%,
which suggests these are possible HR candidates. (Group B) HA SNV ratio ;33% and PGK ;40%
suggest one copy of random integration. (Group C) The ratio suggests that these clones retained only
one copy of the neomycin selection gene. (Group D) Poorly growing ES cells with heavy, G418-resistant
MEF contamination. (Group E) ES cells that may have experiencedmultiple integrations. Note that nine
out of 10 positive clones from (red dots)N1::CreERT2, one out of one from (red square)N2::Cre, and four
of four from (red triangles)N1-N2 fall within group A. (C ) When only one SNV is used for pyroscreening,
the enrichment for positive clones is roughly threefold. This is increased tomore than fourfold when two
SNVs are combined.
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DNA PCR products are then purified with streptavidin-conjugated
Sepharose beads and used for pyrosequencing analysis. The whole
procedure is high-throughput-friendly, and 96 samples could be
processed within 3–4 h (from the setup of PCR reactions to the
obtaining of pyrosequencing results). This three-primer PCR re-
action system (Fakhrai-Rad et al. 2002; Royo et al. 2007) was used
for the amplification of the DNA fragments containing an SNV in
a PCR reaction mixture containing 2 mL of DNA template, 12.5 mL
of Bullseye Taq DNA Polymerase Mix (Midsci), 1 mL of untailed
gene-specific primer, 0.2mL of tailed gene-specific primer, 0.8mL of
UBP-labeled (all at a concentration of 5 mM), and 8 mL of distilled
water (primer sequences are provided in Supplemental Table S2).
PCR conditions were 8 min at 95°C followed by 40 cycles at 95°C
(30 sec), 60°C (30 sec), and 72°C (30 sec).
Single-strand PCR products were purified as described
(Bruinsma et al. 2008). Briefly, single-stranded biotinylated PCR
products were immobilized on streptavidin-coated Sepharose
beads in a vacuum prep tool (Biotage). For each reaction, 40 mL of
Binding Buffer (10 mM Tris-HCl, 2 M NaCl, 1 mM EDTA, 0.1%
Tween 20 at pH 7.6), 20 mL of double-distilled water, and 3 mL of
Streptavidin Sepharose High Performance beads (GE Healthcare)
weremixed together with 20mL of PCR product for 10min at room
temperature using an Eppendorf Thermomixer. After immobiliza-
tion, vacuum was applied to the prep tool and the template was
captured on filter probes. The non-biotinylated template was then
denatured by alkali treatment and removed by washing for 5 sec in
70% EtOH, 0.2 MNaOH denaturation solution (5 sec), and 10mM
tris-acetate washing buffer (pH 7.6) for 5 sec. The last washing step
neutralized the pH. Next, the vacuum was released, and the beads
were transferred into a Biotage PSQ 96 well plate containing the
sequencing primer (5 pmol) and 40 mL of annealing buffer (20mM
tris-acetate, 2 mM MgAc2 at pH 7.6). The pyrosequencing re-
actions were performed using a PSQ96-MA machine (Biotage)
according to the manufacturer’s instructions using the Pyro Gold
reagent kit (Biotage). Assays were performed using cyclic enzyme
and nucleotide dispensation, followed by analysis using the SNV
Software (Biotage).
ES cells from individual clones were trypsinized and har-
vested. Genomic DNA was purified as described (Laird et al. 1991)
and dissolved in 50 mL of TE (pH 8.0). For pyroscreening, 2 mL of ES
cell genomic DNA (unknown concentration) was used for PCR
reaction, followed by single-strand DNA purification and pyrose-
quencing. Clones with an SNV ratio between 40% and 60% were
considered as positive candidates for further screening.
RQPS
For RQPS, the concentration of both genomic DNA and the line-
arized RQPS probe was measured. At least two mixtures of geno-
mic DNA/RQPS probe were then prepared, in which the molar
ratio between the two was between 9:1 and 1:9 (we used 1:1 and
1:2 when two mixtures were done). When 30 ng of mouse or hu-
man genomic DNA is used, for an RQPS probe with the size of 3–4
kb, 0.03–0.04 pg is required to get a roughly 1:1 molar ratio. For
the detailed calculation method, please see http://www.med.
umich.edu/tamc/spike.html. A 2-mL sample from each mixture
was used as the template for the PCR reactions with reference or
query specific primers, followed by single-strand DNA purification
and pyrosequencing.
Mathematical derivation of gene copy numbers with RQPS
To calculate the copy number of a query gene in a genome (t), we
created a mixture containing (a) genomes and (b) molecules of
RQPS probe. Since each RQPS probe contains one reference se-
quence, there are (b) R-SNVnucleotides in themixture. In contrast,
each diploid genome contains two alleles of the autosomal refer-
ence gene and (t) copies of the query gene. Thus, the number of Rs-
SNVnucleotide is (2a) and the number of Qs-SNV is (ta). Therefore,
the fraction of the R-SNV in the mixture (m) is equal to the molar
ratio R-SNV/(R-SNV + Rs-SNV) or:
m = b=ð2a + bÞ: ð1Þ
Likewise, the fraction of the Q-SNV in the mixture (n) is
n = b=ðta + bÞ: ð2Þ
Equation 1 could be solved for b:
b = 2 3 a 3 m=ð1  mÞ ð3Þ
and, similarly, Equation 2 could be solved for b:
b = t 3 a 3 n=ð1  nÞ: ð4Þ
Thus,
2 3 a 3 m=ð1  mÞ = t 3 a 3 n=ð1  nÞ
and can be further solved to:
m=ð1  mÞ = 0:5 3 t 3 n=ð1  nÞ ð5Þ
and
t = 2mð1  nÞ=ð1  mÞn: ð6Þ
When the value [m/(1  m)] is plotted against [n/(1  n)], a line
passing the origin will have the slope k that equals half of the
transgene copy number in the genome (k = 0.5t). If a single-copy
gene is used as reference, k = t.
For the detection of the loss of one allele in ES cells, con-
tamination from feeder cells needs to be considered. If MEF cells
are present in cases in which only nonhomologous recombination
occurs, the copy number of targeted alleles per genomewill remain
2. If the ES cell undergoes homologous recombination, there is
only one targeted allele in each genome of the ES cell, whereas two
copies of the targeted allele are present in the MEF genome. This
will result in higher t values than the expected 0.5, resulting in
a false-negative.
Data process
All pyrosequencing data were processed with Microsoft Excel.
m/(1m) was plotted against n/(1 n), and linear data trend lines
were forced to have a zero intercept.
Generation of animals with defined copy number of Notch1
exon 30
To generate animalswith one, two, three, and four copies of exon30
but with a diploid number of theNotch1 extracellular domain (exon
23), we used the N1::Cre line (Vooijs et al. 2007) in which Cre re-
placed exon 30 in one allele, and theGt(ROSA)26SorNotch (Murtaugh
et al. 2003) line in which one copy of the Gt(ROSA)26Sor locus is
replaced with a cDNA encoding N1ICD to generate a mouse with
three copies of exon 30. Wild-type animals have two alleles of
Notch1, and homozygous N1+/+; Gt(ROSA)26Sor Notch/Notch has four
copies of exon 30.
Array-CGH
Array-CGH was carried out as described (Schwarzbraun et al.
2009).
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